Melior Is Selected as a Top 20 CRO by Pharma Tech Outlook
– Melior has cover appearance on this industry-leading magazine
– Melior is recognized for the combination of its attention to quality, culture and, innovative offering
Melior Is Selected as a Top 20 CRO by Pharma Tech Outlook
– Melior has cover appearance on this industry-leading magazine
– Melior is recognized for the combination of its attention to quality, culture and, innovative offering
VESTECK , Inc. is excited to announce that the U.S. Patent Application No. 17/841,373 Title: REMOTE SURGICAL SUTURE SYSTEM, has been allowed by the U.S. Patent and Trademark Office (USPTO)
Immunome Publishes Preclinical Research Demonstrating that Inhibition of IL-38 Using an Antibody Leads to Anti-Tumor Activity
Relmada Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results
SIRPant Immunotherapeutics Announces FDA Clearance of IND Application for SIRPant-M™ Autologous SIRPαlow Activated Macrophage Immunotherapy